The use of Abdala in children over 5 years of age is authorized in Mexico
Internet
1 julio, 2023
Abdala vaccine receives approval for use in children in Mexico
The Business Group of the Biotechnological and Pharmaceutical Industries of Cuba (BioCubaFarma) confirmed on its Twitter account that the anti-Covid-19 Abdala vaccine received approval in Mexico for use in children
Havana Cuba. – The Business Group of the Biotechnological and Pharmaceutical Industries of Cuba (BioCubaFarma) confirmed on its account on the social network Twitter that the anti-Covid-19 vaccine Rather received approval in Mexico for use in children.
The information from BioCubaFarma specifies that the preparation, after several checks and tests, received approval from the Mexican Regulatory Authority Cofepris, to be used in pediatric ages from 5 years of age.
After a rigorous evaluation process, the Cuban anticovid-19 vaccine, #Abdala receives approval from the Mexican Regulatory Authority Cofepris, to be used in pediatric ages from 5 years of age.#CubanScience pic.twitter.com/6vVz1K8dX8
— BioCubaFarma (@BioCubaFarma) July 1, 2023
In the midst of the Covid-19 pandemic that mourned the world, Cuban researchers from the Center for Genetic Engineering and Biotechnology achieved a preparation against the SARS-CoV-2 coronavirus, recognized by the Pan American Health Organization (PAHO) with an effectiveness of 92.28 percent to prevent diseases and severe complications from the pathogen.
Cuba successfully used the vaccine Rather for the protection of children, adolescents and adults against Covid-19, an antigen that has now received authorization from the Mexican Regulatory Authority Cofepris for its application in infants over 5 years of age.
2023-07-02 03:42:42
#Abdala #vaccine #receives #approval #children #Mexico
